Home > BIGG > Search result

    Results: 3

    Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment

    Chianelli, M; Busetto, L; Vettor, R; Annibale, B; Paoletta, A; Papini, E; Albanese, A; Carabotti, M; Casarotto, D; De Pergola, G; Disoteo, O E; Grandone, I; Medea, G; Nisoli, E; Raffaelli, M; Schiff, S; Vignati, F; Cinquini, M; Gonzalez-Lorenzo, M; Fittipaldo, V A; Minozzi, S; Monteforte, M; Tralongo, A C; Novizio, R; Persichetti, A; Samperi, I; Scoppola, A; Borretta, G; Carruba, M; Carbonelli, M G; De Luca, M; Frontoni, S; Corradini, S. G; Muratori, F; Attanasio, R.
    J. endocrinol. invest; 47 (6), 2024
    This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a g...
    Obesity/complications, Overweight/complications, Bariatric Surgery, Anti-Obesity Agents/therapeutic use, Obesity/drug therapy
    Fulltext

    AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

    Grunvald, Eduardo; Shah, Raj; Hernaez, Ruben; Chander, Apoorva Krishna; Teigen, Levi M; Sultan, Shahnaz; Sigh, Siddarth; Daviikov, Perica.
    Gastroenterology; 163 (5), 2022
    Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
    Heart Disease Risk Factors, Insulin Resistance, Obesity/drug therapy, Appetite Depressants, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2/prevention & control, Topiramate/therapeutic use, Anti-Obesity Agents/therapeutic use
    Fulltext